This Week at FDA: FDA’s final LDT rule nears, Cardinal Health warning letter, and more
This Week at FDAJoanne S. Eglovitch • Michael Mezher
Medical DevicesPharmaceuticalsUnited StatesThis Week at FDAJoanne S. Eglovitch • Michael MezherMedical DevicesPharmaceuticalsUnited States